Selenium And Prostate Cancer: Systematic Review And Meta-analysis
| Effect | Decrease |
| Trial Design | Meta analysis |
| Trial Length | n/a |
| Number of Subjects | 12 |
| Sex | n/a |
A relative decrease in prostate cancer risk is seen when 170ng/mL (circulating selenium levels) is compared to 60ng/mL, where the former value has a 0.8 relative risk when compared to the latter; a slight, but statistically significant reduction in risk.
